Free shipping on all orders over $ 500

GSK2795039

Cat. No. M10049
GSK2795039 Structure
Synonym:

GSK-2795039

Size Price Availability Quantity
1mg USD 70  USD70 In stock
2mg USD 100  USD100 In stock
5mg USD 175  USD175 In stock
10mg USD 267  USD267 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

GSK2795039 is the first small molecule NADPH oxidase 2 (NOX2) inhibitor, with a mean pIC50 of 6 in different cell-free assays. GSK2795039 inhibits reactive oxygen species (ROS) production and NADPH consumption. GSK2795039 shows activity in a murine model of acute pancreatitis, GSK2795039 (100 mg/kg; i.p.) decreases activity in a murine model of acute pancreatitis, reducing the levels of serum amylase triggered by systemic injection of cerulein.

Protocol (for reference only)
Cell Experiment
Cell lines BV2 microglia cell
Preparation method Experimental groups were treated with FeSO4 tetrahydrate (100 μM), LPS serotype 026:B6 (100 ng/ml), ferrous ammonium sulfate (Fe(NH4)2(SO4)2) (100 μM), (sodium sulfate) Na2SO4 (100 μM), or DFO (250 μM). All treatments were added simultaneously and all tests were performed 24 h after treatment. In subsequent experiments, microglia were treated with GKT137831 (50 μM), GSK2795039 (25 μM), or vehicle dimethyl sulfoxide (DMSO) (≤ 1%). These treatments were given simultaneously to the cultures and all assays were conducted 24 h afterwards.
Concentrations 25 μM
Incubation time 24 h
Animal Experiment
Animal models Male Sprague-Dawley (SD) rats, C57BL6/J mice, gp91phox knockout mice
Formulation dissolved in 20% DMSO, 20% Tween 80, 60% polyethylene glycol 200, dose volume of 2 ml/kg
Dosages 2-100 mg/kg
Administration i.p. injection
Chemical Information
Molecular Weight 450.56
Formula C23H26N6O2S
CAS Number 1415925-18-6
Solubility (25°C) DMSO ≥ 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Young J Yauger, et al. J Neuroinflammation. Iron accentuated reactive oxygen species release by NADPH oxidase in activated microglia contributes to oxidative stress in vitro

[2] Edgar Pick. Antioxid Redox Signal. Absolute and Relative Activity Values in Assessing the Effect of NADPH Oxidase Inhibitors

[3] Kazufumi Hirano, et al. Antioxid Redox Signal. Discovery of GSK2795039, a Novel Small Molecule NADPH Oxidase 2 Inhibitor

Related NADPH Oxidase Products
Fluoflavine

Fluoflavine is a selective NOX1 inhibitor with an IC50 value of 90 nM.Fluoflavine is >100 times more selective for NOX1 than NOX2, NOX3, NOX4, and has an IC50 >10 μM for all of them.Fluoflavine was shown to be a selective inhibitor of NOX1 with an IC50 of 360 nM in HEK293 cells.

NoxA1ds

NoxA1ds is a highly efficacious and selective Nox1 (NADPH oxidase isoform 1) inhibitor.

GLX481369

GLX481369 is a redox active substance.

Noxa B BH3

Noxa B BH3 is a biological active peptide.

Noxa A BH3

Noxa A BH3 is a biological active peptide.

  Catalog
Abmole Inhibitor Catalog




Keywords: GSK2795039, GSK-2795039 supplier, NADPH Oxidase, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.